pharma · Lung Cancer
Shiyou Wei
Shiyou Wei is a pharma organization headquartered in CN. Primary therapeutic focus areas include Lung Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from publ
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Dexmedetomidine
Unknown · small molecule · Lung Cancer
Dexmedetomidine for Lung Cancer is a Unknown program (small_molecule) at Shiyou Wei with 1 ClinicalTrials.gov record(s).
Internal code 2022LY0416
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shiyou Wei
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Lung Cancer
- Status
- completed
- Trials
- 1